Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. STOCKGOODIES Message Board

$GTCH The open research is focused on the efforts

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 25562
(Total Views: 197)
Posted On: 12/08/2020 11:59:27 AM
Avatar
Posted By: Lets Roll
$GTCH The open research is focused on the efforts combining Kirlian imaging with the use of machine learning technology to possibly detect early disease symptoms. GBT/Tokenize is conducting experiments with a few advanced algorithms, one of them is a private derivative of the Genetic algorithm. The genetic algorithm is a method for solving both constrained and unconstrained optimization problems that are based on natural selection, the process that drives biological evolution. The algorithm is planned to find pattern similarities in Kirlian images in living tissues in order to categorize potential health related issues. Kirlian imaging produces typical features such as graphical protuberances, halos, and discharge patterns, which can be analyzed by an AI computer program as unique patterns, and categorized as possible criteria for early symptoms identification. GBT/Tokenize is conducting experiments with advanced algorithms and methods to analyze energy fields generated by living organs at set periods. These image's auras will be graphically analyzed to determine patterns that are associated with possible health related symptoms. GBT/Tokenize plans to develop neural network based pattern recognition technology to detect-and-associate unique patterns with related, possible health issues. The research is planned to be conducted over a period of one year and based on its results the company will evaluate the feasibility of implementation of such techniques within its qTerm human vitals product in order to provide further health information for the user's benefit.

https://www.nasdaq.com/press-release/gbt-toke...2020-12-01


(0)
(0)




Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us